Fig. 3From: Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trialMean change from baseline in composite cognitive score over 60 months (intention-to-treat population, n = 483). MI multidomain intervention, Amyloid+ positive amyloid status, Amyloid − negative amyloid statusBack to article page